Sheng Hu
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Ef Malignant Pleural Effusion, Malignant Peritoneal Effusion | EARLY_Phase 1 | 2020-07-24 |